Tue, June 06 2006 10:00 AM
Dharmacon and amaxa Co-promote Improved Delivery of siRNA into Cells
As of June 6, 2006, amaxa and 
Dharmacon, the world's leading supplier of innovative RNA and RNA interference (RNAi) research products, have agreed to collaborate to enhance siRNA delivery into difficult-to-transfect cell types.
“The combined technologies of Dharmacon and amaxa enable us to broaden the application of siRNA so that it can be introduced into difficult cell lines, and with the 96-well Shuttle researchers can also accomplish this in high throughput,” said William S. Marshall, Ph.D., vice president of technology and business development for Fisher Biosciences. “We will work closely with amaxa to provide our customers with coordinated technical service, pre-tested protocols and application models to optimize the use of our siRNA reagents with the amaxa technology.”
The partnership focuses on the delivery of Dharmacon's advanced design siGENOME siRNA libraries using amaxa's new Nucleofector 96-well Shuttle System.
